Oliver Harschnitz
Affiliations: | Sloan Kettering Institute, New York, NY, United States |
Google:
"Oliver Harschnitz"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Vieira de Sá R, Sudria-Lopez E, Cañizares Luna M, et al. (2024) ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes. Nature Communications. 15: 7484 |
van Rheenen W, Diekstra FP, Harschnitz O, et al. (2018) Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. Plos One. 13: e0198874 |
van Rheenen W, Shatunov A, Dekker AM, et al. (2016) Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nature Genetics. 48: 1043-8 |
van den Heuvel DM, Harschnitz O, van den Berg LH, et al. (2014) Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends in Molecular Medicine. 20: 25-35 |